These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9873062)

  • 21. Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells.
    Uchida Y; Itoh M; Taguchi Y; Yamaoka S; Umehara H; Ichikawa S; Hirabayashi Y; Holleran WM; Okazaki T
    Cancer Res; 2004 Sep; 64(17):6271-9. PubMed ID: 15342415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
    Kartal Yandım M; Apohan E; Baran Y
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucosylceramide synthase and apoptosis.
    Bleicher RJ; Cabot MC
    Biochim Biophys Acta; 2002 Dec; 1585(2-3):172-8. PubMed ID: 12531551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia.
    Itoh M; Kitano T; Watanabe M; Kondo T; Yabu T; Taguchi Y; Iwai K; Tashima M; Uchiyama T; Okazaki T
    Clin Cancer Res; 2003 Jan; 9(1):415-23. PubMed ID: 12538495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells.
    Liu YY; Han TY; Yu JY; Bitterman A; Le A; Giuliano AE; Cabot MC
    J Lipid Res; 2004 May; 45(5):933-40. PubMed ID: 14967819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosine-phosphorylation and activation of glucosylceramide synthase by v-Src: Its role in survival of HeLa cells against ceramide.
    Honda T; Motoyoshi K; Kasahara J; Yamagata K; Takahashi H; Nakamura H; Murayama T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158817. PubMed ID: 32980536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
    Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
    Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.
    Gupta V; Patwardhan GA; Zhang QJ; Cabot MC; Jazwinski SM; Liu YY
    J Lipid Res; 2010 Apr; 51(4):866-74. PubMed ID: 19826105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
    Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM
    Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced UDP-glucose Levels Are Associated with P-glycoprotein Over-expression in L1210 Cells and Limit Glucosylceramide Synthase Activity.
    Turáková K; Pavlíková L; Messingerová L; Lakatoš B; Breier A; Sulová Z
    Anticancer Res; 2015 May; 35(5):2627-34. PubMed ID: 25964538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to the antiproliferative effect induced by a short-chain ceramide is associated with an increase of glucosylceramide synthase, P-glycoprotein, and multidrug-resistance gene-1 in cervical cancer cells.
    Gutiérrez-Iglesias G; Hurtado Y; Palma-Lara I; López-Marure R
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):809-17. PubMed ID: 25113261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo.
    Khiste SK; Hosain SB; Dong Y; Uddin MB; Roy KR; Hill RA; Liu Z; Liu YY
    Sci Rep; 2017 Jun; 7(1):2976. PubMed ID: 28592871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells.
    Lucci A; Giuliano AE; Han TY; Dinur T; Liu YY; Senchenkov A; Cabot MC
    Int J Oncol; 1999 Sep; 15(3):535-40. PubMed ID: 10427136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells.
    Ponnapakam AP; Liu J; Bhinge KN; Drew BA; Wang TL; Antoon JW; Nguyen TT; Dupart PS; Wang Y; Zhao M; Liu YY; Foroozesh M; Beckman BS
    Bioorg Med Chem; 2014 Feb; 22(4):1412-20. PubMed ID: 24457089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
    Tyler A; Johansson A; Karlsson T; Gudey SK; Brännström T; Grankvist K; Behnam-Motlagh P
    Exp Cell Res; 2015 Aug; 336(1):23-32. PubMed ID: 26004871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
    Chapman JV; Gouazé-Andersson V; Karimi R; Messner MC; Cabot MC
    Exp Cell Res; 2011 Jul; 317(12):1736-45. PubMed ID: 21396934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin influences the expression of glucosylceramide synthase in invasive ductal breast cancer.
    Zhang X; Wu X; Su P; Gao Y; Meng B; Sun Y; Li L; Zhou Z; Zhou G
    PLoS One; 2012; 7(11):e48492. PubMed ID: 23133636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of artificial microRNA targeting glucosylceramide synthase on drug sensitivity of breast cancer cells].
    Sun YL; Gao P; Zhang XF; Gao YS; Zhou GY
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3296-9. PubMed ID: 23328518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
    Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinoma.
    Liu YY; Patwardhan GA; Xie P; Gu X; Giuliano AE; Cabot MC
    Int J Oncol; 2011 Aug; 39(2):425-31. PubMed ID: 21617856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.